Universal Technical Institute
UTI
19.85
-0.04
-0.20%
Universal Technical Institute
US · UTI
#3186 by market cap
19.85
-0.04
-0.20%
Live - 5344 symbols - heartbeat 138s ago
· 2026-10-08 09:50
Pre-market
19.89
0.00%
After-hours
19.89
0.00%
- Market cap
- 1.09B
- P/E (TTM)i
- 32.54
- P/Bi
- 3.18
- EPSi
- 1.13
- Div yieldi
- 0.00%
- 52W posi
- 5%
Reader sentiment
Are you bullish or bearish on UTI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.86, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +14.05% YoY
Margins
- Gross margin
- 49.68%
- Operating margin
- 9.99%
- Net margin
- 7.54%
Key ratios & quality
- Enterprise valuei
- 1.03B
- PEG ratioi
- 0.94
- Altman Z-Scorei
- 2.86
PEG uses trailing P/E against the 3-year net income growth rate (34.59%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 316.97M | 331.50M | 300.76M | 335.08M | 418.77M | 607.41M | 732.69M | 835.62M |
| Gross profit | 134.38M | 153.19M | 144.83M | 168.27M | 211.53M | 277.54M | 348.16M | 415.13M |
| Selling & admin expenses | 169.65M | 160.99M | 148.70M | 153.32M | 189.16M | 256.14M | 289.27M | 331.66M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -35.28M | -7.80M | -3.87M | 14.95M | 22.37M | 21.40M | 58.89M | 83.47M |
| Pretax profit | -35.70M | -7.67M | -2.59M | 15.18M | 20.44M | 18.09M | 56.23M | 84.27M |
| Tax | -3.02M | 203.00K | -10.60M | 602.00K | -5.41M | 5.77M | 14.23M | 21.26M |
| Net profit | -32.68M | -7.87M | 8.01M | 14.58M | 25.85M | 12.32M | 42.00M | 63.02M |
| Basic EPS | -2 | -1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Diluted EPS | -1.51 | -0.52 | 0.05 | 0.17 | 0.38 | 0.13 | 0.75 | 1.13 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 207.45M | 204.30M | 222.44M | 220.84M | 221.40M | 218.91M |
| Gross profit | 104.96M | 98.69M | 110.18M | 110.40M | 103.97M | 100.57M |
| Selling & admin expenses | 88.11M | 84.54M | 85.20M | 94.71M | 103.63M | 97.33M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 16.85M | 14.15M | 24.99M | 15.69M | 339.00K | 3.25M |
| Pretax profit | 16.83M | 14.35M | 25.56M | 16.21M | 383.00K | 3.10M |
| Tax | 5.39M | 3.69M | 6.80M | 3.39M | -50.00K | 820.00K |
| Net profit | 11.45M | 10.66M | 18.76M | 12.83M | 433.00K | 2.28M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.21 | 0.19 | 0.34 | 0.23 | 0.01 | 0.04 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 116.80M | 118.10M | 180.18M | 183.39M | 135.95M | 204.99M | 221.95M | 246.63M |
| Cash & ST investments | 58.10M | 65.44M | 114.86M | 133.72M | 95.37M | 151.55M | 161.90M | 169.15M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 282.28M | 270.53M | 441.98M | 512.57M | 552.91M | 740.69M | 744.58M | 826.14M |
| Total current liabilities | 92.46M | 96.84M | 121.64M | 132.72M | 137.72M | 184.70M | 204.96M | 229.67M |
| Short-term debt | 1.32M | 1.55M | 23.80M | 14.95M | 14.07M | 25.00M | 24.91M | 19.83M |
| Long-term debt | -- | -- | 131.00K | 29.85M | 66.42M | 159.60M | 123.01M | 84.23M |
| Total liabilities | 155,633,000.00 | 156,238,000.00 | 265,459,000.00 | 324,040,000.00 | 337,514,000.00 | 514,718,000.00 | 484,344,000.00 | 498,029,000.00 |
| Total equity | 126.65M | 114.29M | 176.52M | 188.53M | 215.40M | 225.97M | 260.23M | 328.11M |
| Retained earnings | -31.56M | -44.67M | -32.97M | -22.00M | -1.31M | 5.95M | 38.51M | 101.53M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 198.45M | 185.18M | 246.63M | 248.66M | 243.79M | 258.08M |
| Cash & ST investments | 135.69M | 117.83M | 169.15M | 162.81M | 161.98M | 170.12M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 720.44M | 740.76M | 826.14M | 833.96M | 852.19M | 897.86M |
| Total current liabilities | 185.10M | 185.03M | 229.67M | 217.87M | 207.93M | 198.29M |
| Short-term debt | 24.71M | 21.56M | 19.83M | 21.49M | 23.66M | 17.81M |
| Long-term debt | 91.64M | 70.94M | 84.23M | 98.52M | 127.78M | 157.04M |
| Total liabilities | 426,530,000.00 | 433,972,000.00 | 498,029,000.00 | 498,052,000.00 | 512,280,000.00 | 553,556,000.00 |
| Total equity | 293.91M | 306.79M | 328.11M | 335.91M | 339.91M | 344.31M |
| Retained earnings | 72.11M | 82.77M | 101.53M | 114.35M | 114.79M | 117.07M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -13.35M | 21.75M | 11.03M | 55.19M | 46.03M | 49.15M | 85.90M | 97.33M |
| Depreciation & amortization | 15.69M | 15.90M | 36.08M | 29.63M | 32.78M | 45.82M | 51.19M | 56.79M |
| Free cash flow | -34.28M | 15.29M | 1.77M | -6.12M | -33.42M | -7.54M | 61.60M | 55.35M |
| Dividends paid | -6.36M | -5.25M | -5.26M | -5.25M | -5.16M | -5.07M | -1.10M | 0 |
| Stock buybacks / issuance | 0 | 0 | 49.15M | -- | -- | -- | -- | -- |
| Ending cash balance | 72.16M | 80.56M | 88.92M | 145.98M | 66.45M | 156.92M | 167.47M | 134.13M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -789.00K | 18.05M | 57.10M | 3.08M | 3.99M | 10.33M |
| Depreciation & amortization | 13.86M | 14.49M | 14.84M | 15.27M | 15.63M | 17.11M |
| Free cash flow | -11.74M | 6.85M | 40.63M | -19.60M | -27.25M | -21.15M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 100.51M | 73.40M | 134.13M | 97.47M | 93.61M | 135.93M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -30.05 | -10.89 | 1.11 | 5.11 | 6.36 | 2.06 | 15.65 | 21.42 |
| ROA %i | -13.64 | -4.75 | 0.45 | 1.96 | 2.41 | 0.70 | 5.12 | 8.02 |
| ROIC %i | -21.45 | -7.06 | 0.32 | 2.66 | 3.46 | 1.42 | 7.15 | 10.78 |
| 5-year avg ROE %i | -17.09 | -19.57 | -17.71 | -9.38 | -6.07 | 0.35 | 5.66 | 9.72 |
| EBIT margin %i | -10.22 | -1.34 | -0.86 | 4.64 | 5.36 | 4.57 | 8.97 | 10.76 |
| FCF / sales %i | -- | 4.61 | 0.59 | -- | -- | -- | 8.41 | 6.62 |
| Current ratioi | 1.26 | 1.22 | 1.48 | 1.38 | 0.99 | 1.11 | 1.08 | 1.07 |
| Quick ratioi | 0.91 | 0.91 | 1.28 | 1.18 | 0.85 | 0.99 | 0.97 | 0.97 |
| Debt / assetsi | 14.89 | 15.05 | 35.75 | 38.63 | 37.94 | 47.20 | 39.59 | 33.76 |
| LT debt / equityi | 32.15 | 34.27 | 76.04 | 97.11 | 90.87 | 143.66 | 103.69 | 78.96 |
| Interest coveragei | -9.78 | -1.38 | -258.40 | 42.60 | 11.21 | 2.87 | 6.94 | 15.96 |
| Revenue CAGR (3Y) %i | -4.39 | -1.53 | -2.48 | 1.87 | 8.10 | 26.40 | 29.79 | 25.90 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | 15.45 | 42.28 | 34.59 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 21.81 | 23.11 | 21.42 | 17.44 | 13.47 | 10.53 |
| ROA %i | 8.07 | 8.72 | 8.02 | 6.76 | 5.43 | 4.19 |
| ROIC %i | 10.57 | 11.36 | 10.78 | 8.88 | 6.93 | 5.30 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.76 | 11.25 | 10.76 | 9.11 | 6.99 | 5.56 |
| FCF / sales %i | 9.06 | 9.23 | 6.62 | 1.89 | 0.07 | -- |
| Current ratioi | 1.07 | 1.00 | 1.07 | 1.14 | 1.17 | 1.30 |
| Quick ratioi | 0.94 | 0.87 | 0.97 | 0.98 | 1.03 | 1.14 |
| Debt / assetsi | 35.66 | 35.23 | 33.76 | 34.72 | 37.11 | 40.04 |
| LT debt / equityi | 79.01 | 78.05 | 78.96 | 79.81 | 86.07 | 99.23 |
| Interest coveragei | 10.87 | 13.03 | 15.96 | 15.80 | 14.24 | 12.65 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Universal Technical Institute (UTI) is the largest reported line at 63.05% of revenue, across 2 reported segments.
- Concorde follows at 36.95%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Universal Technical Institute (UTI)63.05%
Concorde36.95%
Quote time 2026-10-08 09:50:31 · For reference only, not investment advice and not tailored to your situation.